Heart Failure Reviews

Papers
(The median citation count of Heart Failure Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome74
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program65
Trends and complications associated with acute new-onset heart failure: a National Readmissions Database–based cohort study43
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis42
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction41
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making39
Polypharmacy definition and prevalence in heart failure: a systematic review38
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 202037
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis36
Right ventricular failure: a comorbidity or a clinical emergency?35
The cardiosplenic axis: the prognostic role of the spleen in heart failure31
Can mechanical circulatory support be an effective treatment for HFpEF patients?30
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction28
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris28
Correction to: Is it time to revisit ICD indications?28
The role of TAVR in patients with heart failure: do we have the responses to all questions?28
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?26
Dependence and reduced motor function in heart failure: future directions for well-being25
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution25
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review25
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition25
Advanced cardiovascular multimodal imaging and aortic stenosis24
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?24
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers23
Clinical management of amyloid cardiomyopathy19
Peripartum cardiomyopathy: a review19
Filamin C in cardiomyopathy: from physiological roles to DNA variants19
Speckle tracking echocardiography in heart failure development and progression in patients with apneas18
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers18
Resistance training in heart failure patients: a systematic review and meta-analysis18
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging17
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases17
The use of diflunisal for transthyretin cardiac amyloidosis: a review17
Advanced airway management and respiratory care in decompensated pulmonary hypertension16
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease15
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study14
Targeting mitochondrial dysfunction with elamipretide14
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond14
Letter to the editor to update the article “Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials”14
Left ventricular assist device in cardiac amyloidosis: friend or foe?13
Letter to the Editor13
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure13
Experimental heart failure models in small animals12
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review12
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202112
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era12
New onset nonischemic cardiomyopathy post liver transplantation11
Echocardiographic assessment of cardiac amyloidosis11
Correction to: Cardiac xenotransplantation: a promising way to treat advanced heart failure11
Large animal models of heart failure with preserved ejection fraction10
Deciphering hypertrophic cardiomyopathy with electrocardiography10
Diagnosis of cardiac sarcoidosis: a primer for non-imagers10
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy10
Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?9
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature9
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure9
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials9
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy9
Soluble ST2: a valuable prognostic marker in heart failure8
Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases8
Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools8
Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review8
0.067970037460327